ArticleScientific reports2025
Age-dependent increases in dorsal hippocampal postsynaptic α5GABA-a receptors may be lost in a rat model of Alzheimer's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perioperative neurocognitive disorders: the importance of global systemic interactions.British journal of anaesthesia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Targeting amyloid for inhibition of neurodegeneration and cognitive decline in Alzheimer’s Disease (AD) using selective therapeutics has been mildly successful, but an improved understanding of memory dysfunction on a neural circuitry level may be needed for development of acute nootropics for ongoing memory dysfunction. Here, we focus on the hypothesis that if early onset memory decline can be traced to the hippocampal trisynaptic circuit, then it could serve as a target for therapeutic modulation. Inhibitory GABAergic neurons participate in sharp wave ripple (SPW-R) oscillations in the hippocampal trisynaptic circuit as detected in CA1 during sleep and awake inactivity and are believed to function in memory replay and consolidation. Using the transgenic beta amyloid expressing TgF344-AD rat, which develops frank neurodegeneration and memory impairment with age, we previously discovered that ripple amplitude in 9mo and older TgF344-AD rats are insensitive to the nootropic drug α5IA, a negative allosteric modulator of α5-subunit containing γ-aminobutyric acid type A receptors (α5GABAARs). Here, we ask whether the loss of α5IA potentiation of ripple amplitude might reflect AD-specific downregulation of the predominant extrasynaptic α5GABAAR isoform. To our surprise, however, postsynaptic α5GABAAR levels decrease with aging in the dorsal dentate gyrus (DG) of TgF344-AD while increasing in wt littermates. The results support a model wherein age-associated beta-amyloid inhibits α5GABAAR trafficking. We posit that reducing α5GABAAR trafficking in excitatory specifically to the postsynaptic compartment in dorsal DG, and likely in CA1 neurons, may reduce their ability to shape local field potentials, including ripples, and blunt the pharmacological action of α5IA on ripple amplitude.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.